An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide?+?dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).

Leleu, X, Terpos, E, Sanz, RG, Cooney, J, O“Gorman, P, Minarik, J, Greil, R, Williams, C, Gray, D, Szabo, Z.

http://www.ncbi.nlm.nih.gov/pubmed/27160474